Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
CD8+ T-cell selection, function, and death in the primary immune response in vivo
Margaret F.C. Callan, … , Chris Hatton, Andrew J. McMichael
Margaret F.C. Callan, … , Chris Hatton, Andrew J. McMichael
Published November 15, 2000
Citation Information: J Clin Invest. 2000;106(10):1251-1261. https://doi.org/10.1172/JCI10590.
View: Text | PDF
Article

CD8+ T-cell selection, function, and death in the primary immune response in vivo

  • Text
  • PDF
Abstract

The primary immune response to Epstein Barr virus (EBV) is characterized by striking proliferation of EBV-specific CD8+ T cells. In this study we have investigated the clonal composition and functional properties of the cells mediating this primary response and have analyzed the mechanisms that control the downregulation of the primary response and the selection of memory cells. We show that massively expanded T-cell clones often dominate the primary antigen-specific T-cell response. Despite the enormous extent of expansion, the virus-specific T cells express high levels of intracellular perforin and are potently cytotoxic. They are, however, functionally heterogeneous in their ability to secrete proinflammatory cytokines, with subpopulations of the antigen-specific T cells being hyporesponsive. The primary response is closely regulated, and the majority of cells are programmed to die via a cytokine-rescuable pathway, leaving only small populations of memory T cells surviving. Comparison of the clonal composition of primary and memory responses in vivo shows that the clones that dominate the primary response are relatively heavily culled during the downregulation of the primary response and the establishment of T-cell memory.

Authors

Margaret F.C. Callan, Chrysoula Fazou, Hongbing Yang, Tim Rostron, Kathryn Poon, Chris Hatton, Andrew J. McMichael

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
Death of antigen-specific T cells taken from patients with primary EBV i...
Death of antigen-specific T cells taken from patients with primary EBV infection. (a) PBMCs from HLA-A2+ (NS80, NS81, NS97) and HLA-B8+ (NS51, NS100) individuals with IM and from HLA-A2+ (C1, C3, C4) and HLA-B8+ (C2, C5) healthy EBV-seropositive individuals were cultured for 30 hours in R10. The frequency of live CD8+ T cells that reacted with the HLA-A2/GLCTLVAML or HLA-B8/RAKFKQLL tetrameric complexes as a proportion of the total lymphocytes was calculated at 0 hours and 30 hours. Survival (%) of the tetramer-reactive T cells at 30 hours is shown. (b) PBMCs from an HLA-A2+ (NS80) and HLA-B8+ (NS51) individual with IM were cultured in R10, in R10 in the presence of 100 ng/ml Fas-Fc fusion protein, or in R10 in the presence of 500 ng/ml DR5-Fc fusion protein for 30 hours. Survival (%) of the tetramer-reactive T cells is shown. (c) PBMCs from an HLA-A2+ (NS97) and HLA-B8+ (NS100) individual with IM were cultured in R10, in R10 in the presence of 50 U/ml rIL-2, 100 ng/ml rIL-7 or 100 ng/ml rIL-15. Survival (%) of the tetramer-reactive T cells is shown.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts